Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults (Q71289689)
Jump to navigation
Jump to search
scientific article published on 01 December 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults |
scientific article published on 01 December 1995 |
Statements
Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults (English)
V K Rustgi
C J Schleupner
1 December 1995